ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q3 2023 Earnings Call Transcript

Operator: Good day ladies and gentlemen and welcome to ACADIA Pharmaceuticals Third Quarter 2023 Financial Results Conference Call. My name is Kathy and I will be your coordinator for today.

Related Keywords

United States ,Canada ,Parag Meswani ,Gregory Renza ,Brendan Teehan ,Albert Kildani ,Yatin Suneja ,Tessa Romero ,Mark Schneyer ,Doug Williamson ,Kathie Bishop ,Al Kildani ,Steve Davis ,Health Canada ,Pharmaceuticals Third Quarter ,Rett Community ,Acadia Pharmaceuticals Inc ,Neuron Pharmaceuticals ,Head Of Research ,Nasdaq ,Corporate Communications ,Call Transcript November ,Third Quarter ,Results Conference ,Senior Vice President ,Investor Relations ,Chief Executive Officer ,Chief Operating Officer ,Chief Financial Officer ,Rare Diseases ,External Innovation ,Rare Diseases Franchise ,Private Securities Litigation Reform Act ,Rett Awareness ,Inflation Reduction Act ,Diverse Countries ,Dangerous Gangs ,Ritu Baral ,